2-oxothiazolidine-4-carboxylic acid has been researched along with transforming growth factor beta in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ananth, S; Chan, CC; Ganapathy, V; Lambert, NA; Martin, PM; Promsote, W; Shen, D; Veeranan-Karmegam, R | 1 |
1 other study(ies) available for 2-oxothiazolidine-4-carboxylic acid and transforming growth factor beta
| Article | Year |
|---|---|
L-2-oxothiazolidine-4-carboxylic acid attenuates oxidative stress and inflammation in retinal pigment epithelium.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; ATP-Binding Cassette Transporters; Cation Transport Proteins; Cell Line; Chemokine CCL2; Gene Expression Regulation; Humans; Inflammation; Interleukin-1beta; Interleukin-6; Mice; Mice, Inbred C57BL; Mice, Knockout; Monocarboxylic Acid Transporters; Oxidative Stress; Pyrrolidonecarboxylic Acid; Receptors, G-Protein-Coupled; Receptors, Nicotinic; Retinal Pigment Epithelium; RNA, Messenger; Thiazolidines; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha | 2014 |